Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.
about
A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel diseaseCulture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileumRationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) study. Sarcoidosis protocolRole of the gut microbiota in defining human healthIntestinal microbiota in human health and disease: the impact of probioticsIntestinal microbiota in functional bowel disorders: a Rome foundation reportMycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicitiesMetagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host MicrobiomeMicrobiology and ecology are vitally important to premedical curriculaDiet, microbiome, and the intestinal epithelium: an essential triumvirate?Defining dysbiosis and its influence on host immunity and diseaseInflammatory bowel disease as a model for translating the microbiomeRecent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic reviewThe role of the intestinal context in the generation of tolerance and inflammationIntestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel diseaseComposition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gapsProbiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathologySalmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiotaMicrobiome, Metabolome and Inflammatory Bowel DiseaseInteractions between the microbiota and pathogenic bacteria in the gutMolecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesInflammatory bowel diseaseMicrobial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases.Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease.Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel diseaseIntestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in childrenInteraction between the gut microbiome and mucosal immune system.Microbial fingerprinting detects intestinal microbiota dysbiosis in Zebrafish models with chemically-induced enterocolitis.Heritability and clinical determinants of serum indoxyl sulfate and p-cresyl sulfate, candidate biomarkers of the human microbiome enterotypeDiffering Complex Microbiota Alter Disease Severity of the IL-10-/- Mouse Model of Inflammatory Bowel Disease.Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray.High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.Immunostimulation in the era of the metagenome.High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate modelThe murine appendiceal microbiome is altered in spontaneous colitis and its pathological progressionCharacterization of bacterial community shift in human Ulcerative Colitis patients revealed by Illumina based 16S rRNA gene amplicon sequencingDirect sequencing of the human microbiome readily reveals community differences.Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis.Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings.
P2860
Q21559533-D22ECF64-6C92-4AAC-8C1D-DD7EC6D9B5B4Q22251107-EEC48E26-2A0A-4C51-8399-3F32B76B3E6EQ23911842-BA34E669-996E-4F27-BC22-E6E1094840C7Q24599062-E80740E9-ABDC-435E-87F9-5C16FF79FAD8Q24628739-9675EBAD-64AE-49A7-A212-BC232DC7CF15Q24631357-39E355F0-D998-4B45-B5CE-D7519B60EA59Q24681823-99C09326-8E1D-44D3-A8DE-0CF830FA828CQ26779142-88EA914E-F2B4-42D4-81C1-CAE3AEEFECBDQ26801329-9BE38A7A-E01D-4EF3-A809-62F1FE7D6AB1Q26823069-7B5677AF-4657-407A-9B62-22D16766A01BQ26851835-28E4C92B-4308-43F0-B46B-46750ADB2973Q26853123-1FD7F0FD-DFFC-4D90-BC99-7CCD377AE964Q27000726-E334BDCF-087E-4254-B06E-BDD64026F516Q27001291-5BFA5B46-C805-4B19-85D2-7CC5611CB8B6Q27003192-547EAF53-4297-4E99-AFD7-EA1A9A439F60Q27006760-79B00CB9-FCDC-41C4-A28F-76565BF01090Q27027791-F9835BA4-1A0E-441F-91BB-9DC602346615Q27334139-624AB337-7D8E-4754-A186-EB04CD084456Q28078126-6800CC1E-25EB-4D01-ABFC-1F3DFE3BDB22Q28080209-4C61579F-9D30-400B-BA45-6A547FB9BE57Q28131810-41C9D329-3DFF-4328-986C-F0BBEAC5FF18Q29615500-A7631D94-2326-4F6A-A1D2-2F5F29FF9B28Q33270858-200EC59D-6E1B-4A8F-91DE-29090A2B7CC6Q33341563-BB5E9A6B-3FAD-46DA-96C8-B6891C9CEEDCQ33381601-10464131-260C-45F7-AAD4-9B7ACA1E095DQ33515830-55B74247-6AAC-4E0D-BF41-F2ECA656E703Q33534036-78F47314-9505-403F-BD3D-E6A1089C46B1Q33612504-4061C8BD-7D8E-4C5D-B380-1DC45BB7A040Q33643059-34DB5A02-B38A-439F-AFAE-DB7B98F5C2BCQ33644514-C7B3FB2D-426D-4526-AE37-1B87F15727A8Q33658943-078F24BC-A696-4FCC-A94A-5CDBF04E7B48Q33694531-63342B1E-7E0B-49A7-B06E-F03BA686FE32Q33789592-F96BE81D-A3BA-4CE5-AB9D-C4042E04C0CBQ33827416-93C5FA94-1813-4E83-A0FE-57BED9D09251Q33835890-D5B44936-2855-4810-9E9D-5C2C639AE45AQ33856754-CE4BD47B-7C9C-4738-B2B9-904792D0CF48Q33890694-B072876F-4EDF-4988-AC3B-101597893D19Q33965950-0F347031-2960-4647-B3D2-F8AE74A873D8Q34008761-F0C6D034-9F04-4CCB-8265-667B2289CC92Q34021561-FD362A14-722F-45D8-9431-147E36433342
P2860
Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Differences between tissue-ass ...... isease and ulcerative colitis.
@ast
Differences between tissue-ass ...... isease and ulcerative colitis.
@en
Differences between tissue-ass ...... isease and ulcerative colitis.
@nl
type
label
Differences between tissue-ass ...... isease and ulcerative colitis.
@ast
Differences between tissue-ass ...... isease and ulcerative colitis.
@en
Differences between tissue-ass ...... isease and ulcerative colitis.
@nl
prefLabel
Differences between tissue-ass ...... isease and ulcerative colitis.
@ast
Differences between tissue-ass ...... isease and ulcerative colitis.
@en
Differences between tissue-ass ...... isease and ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Differences between tissue-ass ...... isease and ulcerative colitis.
@en
P2093
Katrin Sommerfeld
Sander J O Veldhuyzen van Zanten
Sharon Gophna
W Ford Doolittle
P2860
P304
P356
10.1128/JCM.01004-06
P407
P50
P577
2006-09-20T00:00:00Z